RFP
ADMA icon

Root Financial Partners’s ADMA Biologics ADMA Stock Holding History

Root Financial Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.96K Buy
440
+61
+16% +$963 ﹤0.01% 2041
2025
Q4 		$6.91K Buy
379
+113
+42% +$1.9K ﹤0.01% 1652
2025
Q3 		$3.9K Buy
+266
New +$4.56K ﹤0.01% 1804

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Root Financial Partners's ADMA Position: Q1 2026 in Review

Root Financial Partners increased its ADMA Biologics (ADMA) stake by 16% in Q1 2026, buying an estimated $963 and bringing the position to 440 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

Root Financial Partners first reported a position in ADMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.91K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Root Financial Partners held 440 shares of ADMA Biologics worth $3.96K as of Q1 2026.
  • Root Financial Partners bought 61 ADMA Biologics shares in Q1 2026, an estimated $963.
  • ADMA Biologics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2041 holding.
  • Root Financial Partners first reported a position in ADMA Biologics in Q3 2025 and has held it in 3 quarters since.
  • Root Financial Partners's ADMA Biologics position peaked at $6.91K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.